Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury

Brain, Behavior, and Immunity

Volumn 51, Issue , 2016, Pages 176-195

  Maldonado Bouchard, Sioui ^a,f   Peters, Kelsey ^b   Woller, Sarah A ^c   Madahian, Behrouz ^d   Faghihi, Usef ^e   Patel, Shivani ^b   Bake, Shameena ^a   Hook, Michelle A ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Memphis   (United States)

^e UNIVERSITY OF INDIANAPOLIS   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Anxiety; Depression; Inflammation; Spinal cord injury

Indexed keywords

ALPHA 2 MACROGLOBULIN; CYTOKINE; AUTACOID;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; EXCITATION; EXPERIMENTAL BEHAVIORAL TEST; HIPPOCAMPUS; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MALE; MENTAL DISEASE ASSESSMENT; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL WELL-BEING; RAT; SPINAL CORD; SPINAL CORD INJURY; ANIMAL; BLOOD; COMPLICATION; CONVALESCENCE; DISEASE MODEL; ENCEPHALITIS; IMMUNOLOGY; LOCOMOTION; METABOLISM; ORGAN SIZE; PAIN; PAIN THRESHOLD; PATHOLOGY; SPRAGUE DAWLEY RAT; THYMUS;

ALPHA-MACROGLOBULINS; ANIMALS; ANXIETY; CYTOKINES; DEPRESSION; DISEASE MODELS, ANIMAL; ENCEPHALITIS; HIPPOCAMPUS; INFLAMMATION; INFLAMMATION MEDIATORS; LOCOMOTION; MALE; ORGAN SIZE; PAIN; PAIN THRESHOLD; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; THYMUS GLAND;

EID: 84940118381     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.08.009     Document Type: Article

References (119)

1. Abdul-Sattar, A.B., Predictors of functional outcome in patients with traumatic spinal cord injury after inpatient rehabilitation: in Saudi Arabia. NeuroRehabilitation 35:2 (2014), 341–347.
2. Anisman, H., Merali, Z., Understanding stress: characteristics and caveats. Alcohol Health Res. World 23:4 (1999), 241–249.
3. Anisman, H., Merali, Z., Poulter, M.O., Hayley, S., Cytokines as a precipitant of depressive illness: animal and human studies. Curr. Pharm. Des. 11:8 (2005), 963–972.
4. Audet, M.C., Anisman, H., Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front. Cell. Neurosci., 7, 2013, 68.
5. Bake, S., Selvamani, A., Cherry, J., Sohrabji, F., Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One, 9(3), 2014, e91427.
6. Basso, D.M., Beattie, M.S., Bresnahan, J.C., A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12 (1995), 1–21.
7. Bluthe, R.M., Castanon, N., Pousset, F., Bristow, A., Ball, C., Lestage, J., Michaud, B., Kelley, K.W., Dantzer, R., Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24:3 (1999), 301–311.
8. Boakye, M., Leigh, B.C., Skelly, A.C., Quality of life in persons with spinal cord injury: comparisons with other populations. JNS: Spine Spec. Suppl. 17:1 (2012), 29–37.
9. Boneberg, E.M., Hartung, T., Molecular aspects of anti-inflammatory action of G-CSF. Inflamm. Res. 51:3 (2002), 119–128.
10. Bora, E., Fornito, A., Pantelis, C., Yucel, M., Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J. Affect. Disord. 138:1–2 (2012), 9–18.
11. Bremner, J.D., Narayan, M., Anderson, E.R., Staib, L.H., Miller, H.L., Charney, D.S., Hippocampal volume reduction in major depression. Am. J. Psychiatry 157:1 (2000), 115–118.
12. Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M., Neveu, P.J., Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26:8 (2001), 797–808.
13. Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A.H., Neveu, P.J., Treatment of cytokine-induced depression. Brain Behav. Immun. 16:5 (2002), 575–580.
14. Capuron, L., Neurauter, G., Musselman, D.L., Lawson, D.H., Nemeroff, C.B., Fuchs, D., Miller, A.H., Interferon-alpha-induced changes in tryptophan metabolism. Biol. Psychiatry 54:9 (2003), 906–914.
15. Capuron, L., Ravaud, A., Miller, A.H., Dantzer, R., Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy. Brain Behav. Immun. 18:3 (2004), 205–213.
16. Choong, M.L., Yong, Y.P., Tan, A.C., Luo, B., Lodish, H.F., LIX: a chemokine with a role in hematopoietic stem cells maintenance. Cytokine 25:6 (2004), 239–245.
17. Connor, T.J., Song, C., Leonard, B.E., Merali, Z., Anisman, H., An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 84:3 (1998), 923–933.
18. Cook, D.N., The role of MIP-1 alpha in inflammation and hematopoiesis. J. Leukoc. Biol. 59:1 (1996), 61–66.
19. Copeland, W.E., Shanahan, L., Worthman, C., Angold, A., Costello, E.J., Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol. Med. 42:12 (2012), 2641–2650.
20. Curtin, N.M., Boyle, N.T., Mills, K.H., Connor, T.J., Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide. Brain Behav. Immun. 23:4 (2009), 535–547.
21. Dahl, J., Ormstad, H., Aass, H.C., Malt, U.F., Bendz, L.T., Sandvik, L., Brundin, L., Andreassen, O.A., The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 45 (2014), 77–86.
22. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9:1 (2008), 46–56.
23. De Boer, S.F., Koolhaas, J.M., Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur. J. Pharmacol. 463 (2003), 145–161.
24. Deshmane, S.L., Kremlev, S., Amini, S., Sawaya, B.E., Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29:6 (2009), 313–326.
25. DeVivo, M.J., Black, K.J., Richards, J.S., Stover, S.L., Suicide following spinal cord injury. Paraplegia 29:9 (1991), 620–627.
26. Dinarello, C.A., Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27 (2009), 519–550.
27. Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., Lanctot, K.L., A meta-analysis of cytokines in major depression. Biol. Psychiatry 67:5 (2010), 446–457.
28. Driscoll, K.E., Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp. Lung Res. 20:6 (1994), 473–490.
29. Dufour, J.H., Dziejman, M., Liu, M.T., Leung, J.H., Lane, T.E., Luster, A.D., IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168:7 (2002), 3195–3204.
30. Duman, R.S., Malberg, J., Thome, J., Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46:9 (1999), 1181–1191.
31. Dumont, R.J., Okonkwo, D.O., Verma, S., Hurlbert, J.R., Boulos, P.T., Ellegala, D.B., Dumont, A.S., Acute spinal cord injury, part I: pathophysiologic mechanisms. Clin. Neuropharmacol. 24:5 (2001), 254–264.
32. Elliott, T.R., Frank, R.G., Depression following spinal cord injury. Arch. Phys. Med. Rehabil. 77:8 (1996), 816–823.
33. Fantuzzi, G., Faggioni, R., Leptin in the regulation of immunity, inflammation, and hematopoiesis. J. Leukoc. Biol. 68:4 (2000), 437–446.
34. Ferguson, A.R., Hook, M.A., Garcia, G., Bresnahan, J.C., Beattie, M.S., Grau, J.W., A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury. J. Neurotrauma 21:11 (2004), 1601–1613.
35. Gelis, A., Daures, J.P., Benaim, C., Kennedy, P., Albert, T., Colin, D., Joseph, P.A., Pelissier, J., Fattal, C., Evaluating self-reported pressure ulcer prevention measures in persons with spinal cord injury using the revised skin management needs assessment checklist: reliability study. Spinal Cord 49:5 (2011), 653–658.
36. Hastie, T., Tibshirani, R., Friedman, J., Franklin, J., The elements of statistical learning: data mining, inference and prediction. Math. Intelligencer 27:2 (2005), 83–85.
37. Hayashi, M., Ueyama, T., Nemoto, K., Tamaki, T., Senba, E., Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J. Neurotrauma 17:3 (2000), 203–218.
38. Hayes, K.C., Hull, T.C., Delaney, G.A., Potter, P.J., Sequeira, K.A., Campbell, K., Popovich, P.G., Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with chronic spinal cord injury. J. Neurotrauma 19:6 (2002), 753–761.
39. Herrick, S., Elliott, T.R., Crow, F., Self-appraised problem-solving skills and the prediction of secondary complications among persons with spinal cord injuries. J. Clin. Psychol. Med. Settings 1:3 (1994), 269–283.
40. Holsboer, F., The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23:5 (2000), 477–501.
41. Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 71:2 (2009), 171–186.
42. Jezierski, M.K., Sohrabji, F., Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol. Aging 22:2 (2001), 309–319.
43. Jin, W., Dong, C., IL-17 cytokines in immunity and inflammation. Emerg. Microbes Infect., 2, 2013, e60.
44. Jokic, N., Yip, P., Michael-Titus, A., Priestley, J., Malaspina, A., The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression. BMC Genomics, 11(1), 2010, 633.
45. Juengst, S.B., Kumar, R.G., Failla, M.D., Goyal, A., Wagner, A.K., Acute Inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J. Head Trauma Rehab., 2014.
46. Kapp, A., Zeck-Kapp, G., Czech, W., Schopf, E., The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J. Invest Dermatol. 102:6 (1994), 906–914.
47. Kaster, M.P., Gadotti, V.M., Calixto, J.B., Santos, A.R., Rodrigues, A.L., Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 62:1 (2012), 419–426.
48. Kim, H.Y., Cha, H.J., Kim, H.S., CCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive rats. Hypertens. Res., 2015.
49. Kouro, T., Takatsu, K., IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int. Immunol. 21:12 (2009), 1303–1309.
50. Krieger, M., Both, M., Kranig, S.A., Pitzer, C., Klugmann, M., Vogt, G., Draguhn, A., Schneider, A., The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions. Sci. Rep., 2, 2012, 697.
51. Krugel, U., Fischer, J., Bauer, K., Sack, U., Himmerich, H., The impact of social isolation on immunological parameters in rats. Arch. Toxicol. 88:3 (2014), 853–855.
52. Liaw, A., Wiener, M., Classification and regression by randomForest. R News 2:3 (2002), 18–22.
53. Liu, Y., Ho, R.C., Mak, A., Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139:3 (2012), 230–239.
54. Liu, Y., Ho, R.C., Mak, A., The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int. J. Rheum. Dis. 15:2 (2012), 183–187.
55. Liu, X., Wu, R., Tai, F., Ma, L., Wei, B., Yang, X., Zhang, X., Jia, R., Effects of group housing on stress induced emotional and neuroendocrine alterations. Brain Res. 1502 (2013), 71–80.
56. Liu, Y.N., Peng, Y.L., Liu, L., Wu, T.Y., Zhang, Y., Lian, Y.J., Yang, Y.Y., Kelley, K.W., Jiang, C.L., Wang, Y.X., TNFalpha mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress. Eur. Cytokine Netw. 26:1 (2015), 15–25.
57. Luedtke, K., Maldonado-Bouchard, S., Woller, S.A., Funk, M.K., Aceves, M., Hook, M.A., Assessment of depression in a rodent model of spinal cord injury. J. Neurotrauma, 2014.
58. MacQueen, G.M., Campbell, S., McEwen, B.S., Macdonald, K., Amano, S., Joffe, R.T., Nahmias, C., Young, L.T., Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. U.S.A. 100:3 (2003), 1387–1392.
59. Maes, M., Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 461 (1999), 25–46.
60. Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., Neels, H., Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:11 (1997), 853–858.
61. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M., Verkerk, R., The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:3 (2011), 702–721.
62. Magalhaes, P.V., Jansen, K., Stertz, L., Ferrari, P., Pinheiro, R.T., da Silva, R.A., Kapczinski, F., Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults. J. Psychiatr. Res. 48:1 (2014), 13–15.
63. Makino, M., Kitano, Y., Komiyama, C., Takasuna, K., Human interferon-alpha increases immobility in the forced swimming test in rats. Psychopharmacology (Berl) 148:1 (2000), 106–110.
64. Malaspina, A., Jokic, N., Huang, W., Priestley, J., Comparative analysis of the time-dependent functional and molecular changes in spinal cord degeneration induced by the G93A SOD1 gene mutation and by mechanical compression. BMC Genomics, 9(1), 2008, 500.
65. Maldonado Bouchard, S., Hook, M.A., Psychological stress as a modulator of functional recovery following spinal cord injury. Front Neurol., 5, 2014, 44.
66. Malec, J., Neimeyer, R., Psychologic prediction of duration of inpatient spinal cord injury rehabilitation and performance of self-care. Arch. Phys. Med. Rehabil. 64:8 (1983), 359–363.
67. Marsden, W.N., Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 43 (2013), 168–184.
68. McCullumsmith, C.B., Kalpazian, C., Richards, J.S., Forchheimer, M., Heinemann, A., Richardson, E., Wilson, C., Barber, J., Temkin, N., Fann, J.R., Bombardier, C.H., Investigators, P., Novel risk factors associated with current suicidal ideation and lifetime suicide attempt in individuals with spinal cord injury. Arch. Phys. Med. Rehabil., 2015.
69. Menard, D., Tremblay, E., Ferretti, E., Babakissa, C., Perron, N., Seidman, E.G., Beaulieu, J.F., Anti-inflammatory effects of epidermal growth factor on the immature human intestine. Physiol. Genomics 44:4 (2012), 268–280.
70. Menkes, D.B., MacDonald, J.A., Interferons, serotonin and neurotoxicity. Psychol. Med. 30:2 (2000), 259–268.
71. Menzies-Gow, A., Ying, S., Sabroe, I., Stubbs, V.L., Soler, D., Williams, T.J., Kay, A.B., Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J. Immunol. 169:5 (2002), 2712–2718.
72. Merali, Z., Brennan, K., Brau, P., Anisman, H., Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology 165:4 (2003), 413–418.
73. Merendino, R.A., Di Pasquale, G., De Luca, F., Di Pasquale, L., Ferlazzo, E., Martino, G., Palumbo, M.C., Morabito, F., Gangemi, S., Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression. Mediators Inflamm. 13:3 (2004), 205–207.
74. Miller, A.H., Haroon, E., Raison, C.L., Felger, J.C., Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 30:4 (2013), 297–306.
75. Mohri, M., Rostamizadeh, A., Talwalkar, A., Foundations of Machine Learning. 2012, MIT press.
76. Moon, M.L., Joesting, J.J., Blevins, N.A., Lawson, M.A., Gainey, S.J., Towers, A.E., McNeil, L.K., Freund, G.G., IL-4 knockout mice display anxiety-like behavior. Behav. Genet. 45:4 (2015), 451–460.
77. Mor, F., Quintana, F.J., Cohen, I.R., Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 172:7 (2004), 4618–4623.
78. Morikawa, O., Sakai, N., Obara, H., Saito, N., Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur. J. Pharmacol. 349:2–3 (1998), 317–324.
79. Muller-Berghaus, J., Kern, K., Paschen, A., Nguyen, X.D., Kluter, H., Morahan, G., Schadendorf, D., Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun. 5:5 (2004), 431–434.
80. −/− mice. PLoS One, 8(10), 2013, e78385.
81. Neis, V.B., Manosso, L.M., Moretti, M., Freitas, A.E., Daufenbach, J., Rodrigues, A.L., Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration. Behav. Brain Res. 261 (2014), 336–344.
82. Norman, G.J., Karelina, K., Zhang, N., Walton, J.C., Morris, J.S., Devries, A.C., Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol. Psychiatry 15:4 (2010), 404–414.
83. Pace, T.W., Heim, C.M., A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav. Immun. 25:1 (2011), 6–13.
84. Pae, C.U., The potential role of monocyte chemoattractant protein-1 for major depressive disorder. Psychiatry Invest. 11:3 (2014), 217–222.
85. Pan, J.Z., Ni, L., Sodhi, A., Aguanno, A., Young, W., Hart, R.P., Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 68:3 (2002), 315–322.
86. Paradise, M.B., Naismith, S.L., Norrie, L.M., Graeber, M.B., Hickie, I.B., The role of glia in late-life depression. Int. Psychogeriatr. 24:12 (2012), 1878–1890.
87. Pariante, C.M., Miller, A.H., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 49:5 (2001), 391–404.
88. Poling, A., Cleary, J., Monaghan, M., Burying by rats in response to aversive and nonaversive stimuli. J. Exp. Anal. Behav. 35:1 (1981), 31–44.
89. Porsolt, R.D., Bertin, A., Jalfre, M., Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:2 (1977), 327–336.
90. Post, M.W.M., van Leeuwen, C.M.C., Psychosocial issues in spinal cord injury: a review. Spinal Cord 50:5 (2012), 382–389.
91. Price, J.L., Drevets, W.C., Neurocircuitry of mood disorders. Neuropsychopharmacology 35:1 (2010), 192–216.
92. Pugh, R.C., Fleshner, M., Watkins, L.R., Maier, S.F., Rudy, J.W., The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 25:1 (2001), 29–41.
93. Roman, A., Kreiner, G., Nalepa, I., Macrophages and depression - a misalliance or well-arranged marriage?. Pharmacol. Rep. 65:6 (2013), 1663–1672.
94. Roy, M., Richard, J.-F., Dumas, A., Vallieres, L., CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis. J. Neuroinflamm., 9(1), 2012, 18.
95. Schmidt, F.M., Lichtblau, N., Minkwitz, J., Chittka, T., Thormann, J., Kirkby, K.C., Sander, C., Mergl, R., Fasshauer, M., Stumvoll, M., Holdt, L.M., Teupser, D., Hegerl, U., Himmerich, H., Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J. Psychiatr. Res. 55 (2014), 29–34.
96. Shelton, R.C., Claiborne, J., Sidoryk-Wegrzynowicz, M., Reddy, R., Aschner, M., Lewis, D.A., Mirnics, K., Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 16:7 (2011), 751–762.
97. Shi, Y., Liu, C.H., Roberts, A.I., Das, J., Xu, G., Ren, G., Zhang, Y., Zhang, L., Yuan, Z.R., Tan, H.S., Das, G., Devadas, S., Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know. Cell Res. 16:2 (2006), 126–133.
98. Shin, J.C., Goo, H.R., Yu, S.J., Kim, D.H., Yoon, S.Y., Depression and quality of life in patients within the first 6 months after the spinal cord injury. Ann. Rehabil. Med. 36:1 (2012), 119–125.
99. Smith, R.S., The macrophage theory of depression. Med. Hypotheses 35:4 (1991), 298–306.
100. Soden, R.J., Walsh, J., Middleton, J.W., Craven, M.L., Rutkowski, S.B., Yeo, J.D., Causes of death after spinal cord injury. Spinal Cord 38:10 (2000), 604–610.
101. Spijker, S., Dissection of rodent brain regions. Li, K.W., (eds.) Neuroproteomics, vol. 57, 2011, Springer Humana Press, 13–26.
102. Stockmeier, C.A., Mahajan, G.J., Konick, L.C., Overholser, J.C., Jurjus, G.J., Meltzer, H.Y., Uylings, H.B., Friedman, L., Rajkowska, G., Cellular changes in the postmortem hippocampus in major depression. Biol. Psychiatry 56:9 (2004), 640–650.
103. Suarez, E.C., Krishnan, R.R., Lewis, J.G., The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 65:3 (2003), 362–368.
104. Swain, M.G., Le, T., Chronic cholestasis in rats induces anhedonia and a loss of social interest. Hepatology 28:1 (1998), 6–10.
105. Tabachnick, B.G., Fidell, L.S., Principal Components and Factor Analysis. Using Multivariate Statistics. 2007, Pearson Education Inc., Boston p. 649.
106. Tian, W., Zhang, J., Zhang, K., Yang, H., Sun, Y., Shen, Y., Xu, Q., A study of the functional significance of epidermal growth factor in major depressive disorder. Psychiatr. Genet. 22:4 (2012), 161–167.
107. Treit, D., Pinel, J.P.J., Fibiger, H.C., Conditioned defensive burying: a new paradigm for the study of anxiolytic agents. Pharmacol. Biochem. Behav. 15:4 (1981), 619–626.
108. van West, D., Maes, M., Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression. Neuro Endocrinol. Lett. 20:1–2 (1999), 11–17.
109. Vogelzangs, N., Beekman, A.T.F., de Jonge, P., Penninx, B.W.J.H., Anxiety disorders and inflammation in a large adult cohort. Transl. Psychiatry, 3, 2013, e249.
110. Walker, A.K., Kavelaars, A., Heijnen, C.J., Dantzer, R., Neuroinflammation and comorbidity of pain and depression. Pharmacol. Rev. 66:1 (2014), 80–101.
111. White, G.E., Greaves, D.R., Fractalkine: a survivor's guide: chemokines as antiapoptotic mediators. Arterioscler. Thromb. Vasc. Biol. 32:3 (2012), 589–594.
112. Wu, J., Zhao, Z., Sabirzhanov, B., Stoica, B.A., Kumar, A., Luo, T., Skovira, J., Faden, A.I., Spinal cord injury causes brain inflammation associated with cognitive and affective changes: role of cell cycle pathways. J. Neurosci. 34:33 (2014), 10989–11006.
113. Wynn, T.A., IL-13 effector functions. Annu. Rev. Immunol. 21 (2003), 425–456.
114. Yaguchi, T., Nagata, T., Yang, D., Nishizaki, T., Interleukin-18 regulates motor activity, anxiety and spatial learning without affecting synaptic plasticity. Behav. Brain Res. 206:1 (2010), 47–51.
115. Yalcin, I., Barrot, M., The anxiodepressive comorbidity in chronic pain. Curr. Opin. Anaesthesiol 27:5 (2014), 520–527.
116. Yang, L., Jones, N.R., Blumbergs, P.C., Van Den Heuvel, C., Moore, E.J., Manavis, J., Sarvestani, G.T., Ghabriel, M.N., Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 12:3 (2005), 276–284.
117. Yip, P.K., Malaspina, A., Spinal cord trauma and the molecular point of no return. Mol. Neurodegen., 7(6), 2012.
118. You, Z., Luo, C., Zhang, W., Chen, Y., He, J., Zhao, Q., Zuo, R., Wu, Y., Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behav. Brain Res. 225:1 (2011), 135–141.
119. Young, J.J., Bruno, D., Pomara, N., A review of the relationship between proinflammatory cytokines and major depressive disorder. J. Affect. Disord. 169 (2014), 15–20.